The Cyclic Peptide Ecumicin Targeting ClpC1 Is Active Against Mycobacterium Tuberculosis in Vivo

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.04054-14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Which Aminoglycoside or Fluoroquinolone Is More Active Against Mycobacterium Tuberculosis in Mice?

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1997English

The C-Terminus of ClpC1 of Mycobacterium Tuberculosis Is Crucial for Its Oligomerization and Function

PLoS ONE
Multidisciplinary
2012English

Indoleamides Are Active Against Drug-Resistant Mycobacterium Tuberculosis

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2013English

Rifabutin Is Active Against Mycobacterium Abscessus in Mice

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

In Vitro and in Vivo Activities of the Riminophenazine TBI-166 Against Mycobacterium Tuberculosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Pentacyclic Nitrofurans With in Vivo Efficacy and Activity Against Nonreplicating Mycobacterium Tuberculosis

PLoS ONE
Multidisciplinary
2014English

In Vitro and in Vivo Activity of Contezolid (MRX-I) Against Mycobacterium Tuberculosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Easy-To-Synthesize Spirocyclic Compounds Possess Remarkable in Vivo Activity Against Mycobacterium Tuberculosis

English

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium Tuberculosis

Science
MultidisciplinaryPhilosophy of ScienceHistory
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy